These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22492623)

  • 1. From dynamic combinatorial 'hit' to lead: in vitro and in vivo activity of compounds targeting the pathogenic RNAs that cause myotonic dystrophy.
    Ofori LO; Hoskins J; Nakamori M; Thornton CA; Miller BL
    Nucleic Acids Res; 2012 Jul; 40(13):6380-90. PubMed ID: 22492623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic combinatorial selection of molecules capable of inhibiting the (CUG) repeat RNA-MBNL1 interaction in vitro: discovery of lead compounds targeting myotonic dystrophy (DM1).
    Gareiss PC; Sobczak K; McNaughton BR; Palde PB; Thornton CA; Miller BL
    J Am Chem Soc; 2008 Dec; 130(48):16254-61. PubMed ID: 18998634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting toxic RNAs that cause myotonic dystrophy type 1 (DM1) with a bisamidinium inhibitor.
    Wong CH; Nguyen L; Peh J; Luu LM; Sanchez JS; Richardson SL; Tuccinardi T; Tsoi H; Chan WY; Chan HY; Baranger AM; Hergenrother PJ; Zimmerman SC
    J Am Chem Soc; 2014 Apr; 136(17):6355-61. PubMed ID: 24702247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. rbFOX1/MBNL1 competition for CCUG RNA repeats binding contributes to myotonic dystrophy type 1/type 2 differences.
    Sellier C; Cerro-Herreros E; Blatter M; Freyermuth F; Gaucherot A; Ruffenach F; Sarkar P; Puymirat J; Udd B; Day JW; Meola G; Bassez G; Fujimura H; Takahashi MP; Schoser B; Furling D; Artero R; Allain FHT; Llamusi B; Charlet-Berguerand N
    Nat Commun; 2018 May; 9(1):2009. PubMed ID: 29789616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Dimeric Form of 1,3-Diaminoisoquinoline Derivative Rescued the Mis-splicing of Atp2a1 and Clcn1 Genes in Myotonic Dystrophy Type 1 Mouse Model.
    Matsumoto J; Nakamori M; Okamoto T; Murata A; Dohno C; Nakatani K
    Chemistry; 2020 Nov; 26(63):14305-14309. PubMed ID: 32449537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Ligand That Targets CUG Trinucleotide Repeats.
    Li J; Matsumoto J; Bai LP; Murata A; Dohno C; Nakatani K
    Chemistry; 2016 Oct; 22(42):14881-14889. PubMed ID: 27573860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA Foci, CUGBP1, and ZNF9 are the primary targets of the mutant CUG and CCUG repeats expanded in myotonic dystrophies type 1 and type 2.
    Jones K; Jin B; Iakova P; Huichalaf C; Sarkar P; Schneider-Gold C; Schoser B; Meola G; Shyu AB; Timchenko N; Timchenko L
    Am J Pathol; 2011 Nov; 179(5):2475-89. PubMed ID: 21889481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modifications to toxic CUG RNAs induce structural stability, rescue mis-splicing in a myotonic dystrophy cell model and reduce toxicity in a myotonic dystrophy zebrafish model.
    deLorimier E; Coonrod LA; Copperman J; Taber A; Reister EE; Sharma K; Todd PK; Guenza MG; Berglund JA
    Nucleic Acids Res; 2014 Nov; 42(20):12768-78. PubMed ID: 25303993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA interference targeting CUG repeats in a mouse model of myotonic dystrophy.
    Sobczak K; Wheeler TM; Wang W; Thornton CA
    Mol Ther; 2013 Feb; 21(2):380-7. PubMed ID: 23183533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Plant-derived Alkaloids with Therapeutic Potential for Myotonic Dystrophy Type I.
    Herrendorff R; Faleschini MT; Stiefvater A; Erne B; Wiktorowicz T; Kern F; Hamburger M; Potterat O; Kinter J; Sinnreich M
    J Biol Chem; 2016 Aug; 291(33):17165-77. PubMed ID: 27298317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1.
    Dansithong W; Paul S; Comai L; Reddy S
    J Biol Chem; 2005 Feb; 280(7):5773-80. PubMed ID: 15546872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.
    Ho TH; Savkur RS; Poulos MG; Mancini MA; Swanson MS; Cooper TA
    J Cell Sci; 2005 Jul; 118(Pt 13):2923-33. PubMed ID: 15961406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscleblind protein, MBNL1/EXP, binds specifically to CHHG repeats.
    Kino Y; Mori D; Oma Y; Takeshita Y; Sasagawa N; Ishiura S
    Hum Mol Genet; 2004 Mar; 13(5):495-507. PubMed ID: 14722159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo discovery of a peptide that prevents CUG-RNA hairpin formation and reverses RNA toxicity in myotonic dystrophy models.
    García-López A; Llamusí B; Orzáez M; Pérez-Payá E; Artero RD
    Proc Natl Acad Sci U S A; 2011 Jul; 108(29):11866-71. PubMed ID: 21730182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CAG repeats mimic CUG repeats in the misregulation of alternative splicing.
    Mykowska A; Sobczak K; Wojciechowska M; Kozlowski P; Krzyzosiak WJ
    Nucleic Acids Res; 2011 Nov; 39(20):8938-51. PubMed ID: 21795378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoplasmic CUG RNA foci are insufficient to elicit key DM1 features.
    Dansithong W; Wolf CM; Sarkar P; Paul S; Chiang A; Holt I; Morris GE; Branco D; Sherwood MC; Comai L; Berul CI; Reddy S
    PLoS One; 2008; 3(12):e3968. PubMed ID: 19092997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: two individual consequences of CUG trinucleotide repeats.
    Dhaenens CM; Schraen-Maschke S; Tran H; Vingtdeux V; Ghanem D; Leroy O; Delplanque J; Vanbrussel E; Delacourte A; Vermersch P; Maurage CA; Gruffat H; Sergeant A; Mahadevan MS; Ishiura S; Buée L; Cooper TA; Caillet-Boudin ML; Charlet-Berguerand N; Sablonnière B; Sergeant N
    Exp Neurol; 2008 Apr; 210(2):467-78. PubMed ID: 18177861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Dimeric 2,9-Diamino-1,10-phenanthroline Derivative Improves Alternative Splicing in Myotonic Dystrophy Type 1 Cell and Mouse Models.
    Li J; Nakamori M; Matsumoto J; Murata A; Dohno C; Kiliszek A; Taylor K; Sobczak K; Nakatani K
    Chemistry; 2018 Dec; 24(68):18115-18122. PubMed ID: 30302858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Furamidine Rescues Myotonic Dystrophy Type I Associated Mis-Splicing through Multiple Mechanisms.
    Jenquin JR; Coonrod LA; Silverglate QA; Pellitier NA; Hale MA; Xia G; Nakamori M; Berglund JA
    ACS Chem Biol; 2018 Sep; 13(9):2708-2718. PubMed ID: 30118588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New function for the RNA helicase p68/DDX5 as a modifier of MBNL1 activity on expanded CUG repeats.
    Laurent FX; Sureau A; Klein AF; Trouslard F; Gasnier E; Furling D; Marie J
    Nucleic Acids Res; 2012 Apr; 40(7):3159-71. PubMed ID: 22156369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.